Factors
Stocks
Valuation
Portfolio
Visualizations
More
Research date: October 31, 2026
Closing price before research date: $96.64
Current price: $96.64

Bunge Global SA (NYSE: BG) — The Discount Arrived Before the Cash

Published: 2026-10-31 · Verdict: Accumulate · Entry price: $100 · Price target: $120 · Research confidence: High (80%)

Executive conclusion

Analyst Take

ACCUMULATE at the October 30, 2026 close of $96.64, with a preferred entry at or below $100 and an approximately $120 valuation over 12–18 months. Investment conviction is medium. The 22.4% decline from the September report’s $124.59 reference changes the prospective return more than the latest quarter changes the business assessment. Management retained adjusted EPS guidance of $9.25–$9.75, putting the shares at 10.2 times its midpoint. My approximately $11 sustainable EPS estimate remains an assumption about execution and the cycle. Management’s approximately $13 construction remains prospective. The indicated $2.88 annual dividend adds about 3.0% gross yield, although current conventional free cash flow does not fund the distribution. [S2] (Q3 results)[S8][S20]

The operating case has become more specific. Q3 adjusted EPS increased to $2.56 from $2.27, while adjusted segment EBIT increased to $997 million from $924 million. Soybean earnings improved despite lower processed tonnage, a better test than acquisition-driven volume expansion. Management now describes three approximate 2027 increments of $0.50 per share each: projects, additional cost savings and commercial opportunities. These are management estimates, not formal annual guidance, and they overlap categories already present in the earlier framework. They nevertheless provide milestones against which shareholders can judge whether the enlarged network earns more from existing investment. [S2][S4]

The central tension is that improving earnings coexist with increasing capital requirements. Nine-month operating cash flow was negative $2.302 billion and funded debt reached $16.746 billion. Management expects elevated working capital through year-end and early 2027. Saleable crops make that borrowing more financeable than debt against an unsuccessful acquisition or obsolete plant. They do not make the equity capital-light: selling one inventory parcel often requires buying its replacement to keep customers supplied. The variant perception is that current valuation can compensate for unfinished operating gains while still requiring a large discount for cash realization. An earnings yield is an entitlement to accounting income; it becomes spendable shareholder income only after the system finances itself. [S1][S4]

The strongest counter-case challenges the earnings denominator, not merely the timing of cash. Renewable-fuel demand encourages new crushing capacity, and the associated meal also needs customers. Cost savings may offset inflation or pass to suppliers and buyers through competition. Commercial gains during regional shortages may diminish once normal routes reopen. Specialty and grain earnings weakened in Q3, while company-defined ROIC was 7.0% and inventory-adjusted ROIC 8.8%. Both return measures are non-GAAP. They demonstrate moderate current returns, not a completed transformation into a high-return compounder. Sustainable EPS of $7–$8 remains a meaningful downside possibility. [S2][S3][S17]

My earnings scenarios assign 25%, 50% and 25% probabilities to approximately $70, $126.50 and $156 outcomes, producing $119.75 before dividends. These estimates and weights are analytical judgments. The central outcome assumes substantial conversion of the next-year opportunity, partial delivery of the eventual framework, stabilization of operating capital and limited net share retirement. A deliberately conservative cash sensitivity is less generous: $1.7 billion of recurring annual equity cash, capitalized at a 9% cost-of-equity-minus-growth rate, supports about $98 per share. This disagreement should remain visible. The valuation upside requires cash generation closer to earnings, better capital efficiency or a lower net capitalization rate than that sensitivity assumes.

Evidence against immediate funding distress is substantial. Major revolving maturities were extended, committed undrawn facilities were $8.515 billion, and the company holds marketable physical crops. However, commercial-paper capacity overlaps its committed backing. Level 3 inventory declined sequentially, but transfers between valuation categories contributed; the movement does not independently prove improved physical liquidity. These facts support patience with a funding cycle while rejecting an automatic year-end cash-release assumption. [S1][S23]

Research confidence is higher than investment conviction. Filings, transaction terms and government production data are strong evidence; savings attribution, normalized spreads and future capital release are less secure. The near-term decision sequence is Q4 delivery, December receivables-purchaser renewals, customer qualification, formal 2027 guidance and evidence that ordinary debt stabilizes. I would strengthen the judgment if earnings remain above $10 through softer spreads while both return measures and conventional cash conversion improve. I would reverse it if ordinary-crop guidance falls below $8.50, less than half the identified 2027 operating increments arrive without a credible temporary explanation, or adjusted leverage exceeds 2.5 times alongside continuing cash consumption and no funding remedy. These are analyst decision rules, not company covenants. [S1][S3][S4]

Changes since 2026-09-11

The prior thesis remains partly confirmed: the enlarged earnings opportunity is credible, the full $13 framework is unearned, and cash conversion is the decisive unfinished test. The prior $110 entry threshold first traded on September 22; the latest close is another 12.1% lower. Crossing that threshold establishes execution opportunity, not investment success. The sustainable EPS reference falls from approximately $11.50 to $11 because financing and specialty weakness deserve greater weight. [S2][S20]

New disclosures supersede earlier assumptions. Brazilian mill consideration is approximately $383 million; European spreads proceeds are now expected in 2027. Savings require a precise correction: Investor Day showed approximately $190 million of full-year 2026 savings and a $220 million year-end run rate. The earlier report conflated those quantities. The latest expectation of slightly more than $200 million refers to the annual benefit; $220 million was not an invented number or a directly comparable annual target. [S1][S4][S8]

Two historical interpretations also change. Beneficial-interest collections classified in investing offset much of the raw 2021–22 operating-cash deficit. Omitting them overstated economic cash absorption. The April 2022 intraday high was $128.40, making the subsequent decline to $67.40 approximately 47.5%, rather than the smaller drawdown obtained from a selected $115 reference. Neither correction removes cyclicality. [S7][S20][S32]

The previous expectation of rapid seasonal funding relief has weakened; the latest call explicitly extends elevated working capital into early 2027. Conversely, a claim of uniformly worsening inventory quality is too strong because Level 3 balances declined sequentially. Additional exemption reallocation has advanced to a formal proposal, not a final rule. The prior bull tests concerning sustained earnings, double-digit inventory-adjusted returns and net commercial gains remain open. [S1][S4][S15]

Stock Price Action — Five-Year Event Map

The split-adjusted Company Financials series contains 1,256 daily observations from October 29, 2021 through October 30, 2026. The first close was $92.64; the latest was $96.64. Its intraday low was $67.40 on February 6, 2025 and high $134.865 on June 3, 2026. The latest quotation is 28.3% below that high. The verified 52-week range is $88.24–$134.865; the current price sits about 18% of the way from the range’s low to high. These are price observations without reinvested dividends. Public end-of-day data independently confirm the latest close. [S20] (public price corroboration)

  1. Late 2021–April 2022: the stock advanced from the low $90s to $128.40 intraday. Crop scarcity, war disruption and strong agricultural earnings accompanied the move. Their individual contributions cannot be established from prices. [S20][S31][S32]
  2. April 2022–February 2025: the decline to $67.40 was approximately 47.5%. Earnings normalized and Viterra’s approval process remained unfinished. Those developments are documented; precise return attribution is inference. [S5][S6][S20]
  3. February–July 2025: the February 6 close of $69.29 recovered to $81.39 when Viterra closed on July 2. Completion removed transaction uncertainty without demonstrating acquisition returns. [S1][S20]
  4. December 2025–March 2026: the shares moved from $89.08 to $119.75 around introduction of the post-merger framework. Much appreciation preceded Investor Day, precluding attribution of the entire advance to that presentation. [S8][S20]
  5. March–June 2026: the stock reached its five-year high as guidance and renewable-fuel expectations improved. Stronger expected demand was supportive information; permanently higher processor spreads remained a hypothesis. [S13][S20][S45]
  6. June–September 10: the June 3 closing high of $131.41 gave way to $105.07 on July 30 before recovering to $124.59. Guidance improvement did not prevent a substantial interim reset in confidence. [S10][S20]
  7. September 10–October 30: BG fell 22.4%, including 4.7% on October 29. Better adjusted earnings and unchanged guidance did not arrest the decline. Financing, forward visibility and positioning are plausible explanations, not verified single causes. [S2][S20]

ADM fell 11.5% over the same final interval. A regression of 36 matched daily returns gives BG beta to ADM of approximately 0.98 and R-squared of 0.69. Comparing cumulative returns after scaling ADM by that beta leaves approximately 11 percentage points of additional BG weakness. This is a descriptive short-window calculation, not persistent alpha, an event study or proof of mispricing. [S20][S29]

Verdict: The decline includes a shared industry component and additional BG weakness. The historical record demonstrates that an essential merchant can remain operationally useful while its equity loses nearly half its value.

Business Overview

Bunge connects agricultural producers with food, feed and fuel customers through origination, storage, transportation, merchandising, processing, refining and selected ingredients. Viterra expanded the origination and logistics network around Bunge’s processing footprint. The audited 2025 report identifies approximately 34,000 employees and operations in more than 50 countries. Its current four-segment presentation supersedes older business descriptions that still circulate in financial profiles. Legal incorporation history should likewise not be mistaken for the age of the operating franchise. [S5] (2025 annual filing)

The business is understandable through crop procurement, processing spreads, logistics, utilization and operating capital, although forecasting their interaction is difficult. A farmer wants a competitive local bid and reliable settlement. A feed customer wants consistent meal delivered when needed. A food manufacturer also requires safety, specification and qualified functionality. A fuel producer needs suitable feedstock and eligibility documentation. Bunge earns the residual when its network meets those requirements at a favorable full delivered cost. This is an understandable service with a difficult earnings forecast.

Four connected value chains

Soybean Processing and Refining combines crop origination, crushing, product merchandising, refining and distribution. The processor buys delivered beans and sells oil, protein meal and other co-products. The useful economic spread subtracts beans, conversion costs and logistics from the combined realizable product value. Both main outputs must find buyers. Stronger oil demand may justify more crush, but the resulting meal can depress meal realization. A futures crush calculation therefore supplies a reference, not Bunge’s realized plant margin.

Refining transforms crude oil into customer-ready products. Its economics depend on crude availability, energy, product specification, usable capacity and qualified customers. A multi-oil facility adds procurement flexibility, but substitutions need suitable equipment and customer acceptance. The option to select among inputs can be valuable during disruption; it does not entitle every new ton to a stable refining margin. Cost comparisons must include yields, logistics and the time necessary to change production.

Softseed Processing and Refining applies related economics to canola, rapeseed and sunflower. Crop calendars, oil yields and meal characteristics differ from soybeans. Multiple origins can offset a poor region when transport, available crops and destination economics align. The financial benefit is greater choice of routes and inputs. It is not independence from global vegetable-oil and protein balances. A technically efficient plant can still run below useful capacity if farmers do not sell at economical bids.

Tropical Oils and Specialty Ingredients includes specialty fats, tropical oils, proteins and related ingredients. Customer qualification and formulation should matter more than in bulk grain. However, technical differentiation does not guarantee adequate returns during startup or weak utilization. Q3 adjusted EBIT was $16 million versus $51 million a year earlier. That result challenges any valuation that treats the entire segment as an established specialty franchise before commercial contribution catches up with capability. [S2]

Grain Merchandising and Milling captures differences in origin, destination, quality, storage, timing and freight, together with milling margins. Grain can be more valuable at one destination than another after delivery costs. A merchant earns by solving that mismatch reliably. Disruption can increase route value and simultaneously damage facilities, delay shipments or raise counterparty exposure. Sugar mills inherited with Viterra remain in the reporting perimeter pending disposal, so the segment is not a homogeneous grain fee stream. [S1]

Revenue recurrence and contract quality

Physical demand recurs, but reported revenue and profit remain transactional because commodity prices, spreads and delivery timing determine invoices and contribution. The need to feed people and animals repeats; the margin retained by one intermediary is renegotiated across procurement, processing and delivery. Essential consumption supports throughput and franchise survival more reliably than stable quarterly earnings.

A higher bean price can increase sales and inventory funding without raising economic profit. A lower crop price can reduce sales while releasing cash and preserving processing contribution. Revenue consequently has two roles: it measures the financial scale of transactions and provides a denominator for margins. It is a weak stand-alone measure of competitive progress. Volume, useful utilization, contribution and capital committed to earn that contribution provide a better operating dashboard.

Forward contracts offer some visibility but also create performance obligations. Customers can shorten buying horizons, farmers can withhold crops, and suppliers may fail to deliver the expected quality. A booked physical margin is economically attractive only if delivery, collection and hedging work as planned. A large contract book may reduce one kind of price uncertainty while increasing logistical and credit demands. Contract duration alone does not establish recurring profit.

Most large buyers can qualify several suppliers. Farmers can switch destinations where transport alternatives exist. Relationships persist because execution has value, while price remains important. The company’s market access, balance sheet and operational reliability can make it the preferred counterparty without creating prohibitive switching costs. This distinction explains how repeat business and competitive pricing coexist.

Hedging, credit and service

Commodity, currency, freight and interest-rate derivatives help manage exposures. Economic hedges may affect reported results before the physical transaction they offset. Daily collateral can also precede inventory realization. These mechanisms explain why a physical merchant needs treasury and risk capacity as part of customer service, rather than as an administrative function detached from operating economics. [S5][S9]

An illustrative processor can own crop and sell futures against it. If futures rise, the processor may post cash margin while the crop’s offsetting value remains unsold. The combined transaction may ultimately be profitable. Until settlement, credit bridges a real cash requirement. Hedging reduces some flat-price exposure while leaving basis, volume, location, quality, counterparty and settlement risks. A small net fair-value position is therefore not a sufficient liquidity stress measure.

Assets, ownership form and economic value

Economically valuable assets not fully recognized on the balance sheet include origination relationships, route knowledge, customer qualification, operating systems and supply-chain coordination. Their value should appear in better procurement basis, useful utilization, lower delay costs, customer retention or resilience. If those operating outcomes fail to improve, network breadth can represent extra complexity and capital rather than hidden franchise value.

Old ports, elevators and permits may be difficult to reproduce. Replacement difficulty is relevant but insufficient to establish value above book. A well-positioned corridor may earn more than a new entrant could replicate at reasonable cost. A stranded facility can be worth less than depreciated book. Recognized goodwill already incorporates acquired expectations and must not be added again as a separate unrecognized network asset.

BG is a Swiss registered share listed directly on the NYSE; it is not an ADR, MLP, partnership interest or K-1 security. Redomestication from Bermuda occurred in November 2023 through a one-for-one exchange. Swiss distribution approvals and holder-specific withholding or reclaim treatment can affect after-tax income. The indicated yield used here is gross. [S6]

Verdict: Bunge provides essential recurring physical services through a potentially valuable network. Profit remains the competitive residual after crops, transformation, logistics, risk and financing. The capital needed to deliver those services is integral to business quality.

Industry Dynamics

The market is international and measured in hundreds of millions of tons; consumption grows, while crops, processing capacity and policy determine where profits accrue. Food, feed and fuel are overlapping demands for joint products. Their market estimates cannot be added without double counting crops or outputs. Nominal market dollars also change with crop prices, making physical balances and delivered spreads more useful than a promotional total-addressable-market calculation.

USDA’s October forecast projected a 4.56-billion-bushel US soybean crop, 2.78 billion bushels of crush and 315 million bushels of ending stocks for 2026/27. Finalized 2025/26 crush was 2.646 billion bushels, implying approximately 5.1% projected growth. These are specified marketing-year forecasts, not completed production or consumption. Supply and processing activity are expanding together, supporting potential throughput without guaranteeing attractive incremental margins. [S17] (October outlook)

Competitors, entry and the supply response

Bunge’s annual report identifies ADM, Cargill, Louis Dreyfus, Wilmar and COFCO among its major competitors; CHS, Olam and regional firms matter in particular activities. ADM is the closest listed broad operating peer. Private merchants can be closer network competitors without providing observable equity multiples. AAK and Fuji Oil are more relevant to specialty fats than to the whole company. Meat, egg and salmon producers occupy different economic positions despite sharing agricultural taxonomies. [S5]

Industry profitability is cyclical: building a global platform faces substantial barriers, but incumbent and regional capacity additions can still compress processing spreads. A new global entrant needs financing, risk controls, storage, transport, plants, relationships and jurisdictional knowledge. An incumbent adding a regional processing line needs far less. Thus difficult network replication can coexist with modest through-cycle returns among capable incumbents.

The capital cycle begins when demand raises product values relative to available transformation capacity. Existing operators debottleneck, partners expand and greenfield entrants obtain financing. Construction delays can preserve margins temporarily. Once new assets operate, they compete for crops and customers, adding meal and oil to the same markets. A project can outperform peers through location and integration while contributing to the industry supply response that narrows its original spread.

Farmers, logistics providers, processors, refiners, fuel producers and customers divide the profit pool. Crop scarcity may improve farmer realization and hurt plant utilization. Scarce transport can reward corridor access. Product demand that outruns crush can reward processors. Fuel credits remain downstream unless feedstock demand becomes tight enough to improve oil realization. Owning several stages creates more ways to respond; it does not make all stage-level margin improvements additive.

Local concentration and merger remedies

Canada provides specific evidence of local competitive advantage. The Competition Bureau’s April 22, 2024 report found that Bunge and Viterra operated seven of fourteen Canadian oilseed-crushing facilities and identified procurement and delivered-canola-oil markets where rivalry could weaken. These are dated findings about defined markets, not a current global market-share estimate. They challenge an indiscriminate claim that every crop market is perfectly competitive. [S47]

Approval nevertheless imposed elevator divestitures, G3 independence safeguards, specified canola-oil customer price protection, and investment and operating commitments. Qualifying price-protection volumes extend through 2025–29. These conditions constrain a simple thesis that all merger-created bargaining power becomes shareholder profit. They also belong in the acquisition’s full economic obligations. [S48]

Competition is more concentrated at the global-company level after Viterra, but remains intense at the regional crop-procurement, plant and delivered-product level. Physical geography matters more than a single global concentration ratio. A customer with limited truck alternatives faces a different market from an importer able to switch among ocean origins. The moat must be defined at the corridor where transport and substitutes determine the actual choice set.

Renewable obligations versus observable molecules

EPA’s final 2026–27 rule sets biomass-based-diesel total applicable volumes of 9.07 billion and 9.20 billion RINs, including specified exemption reallocation. RINs are ethanol-equivalent compliance units. They are not physical gallons of soybean oil or renewable diesel. Pathways, equivalence values, inventories and substitutes determine the underlying feedstock requirement. [S13]

EIA’s latest physical observations show soybean-oil biofuel inputs of 1.687 billion pounds in July and 1.400 billion in August, versus 1.108 billion and 1.041 billion a year earlier. January–August use totaled 10.620 billion pounds versus 7.291 billion, approximately 45.7% growth. August declined from July but remained about 34.5% above the prior year. These data verify demand strength, not Bunge’s retained margin. [S16]

USDA forecasts 17.8 billion pounds of soybean-oil biofuel use in 2026/27, more than half domestic consumption, while explicitly linking achievable record crush to capacity added during 2021–26. The same analysis therefore supports the demand thesis and its supply-side counterargument. Calendar-year EIA observations and marketing-year USDA forecasts must remain separate. [S18]

October’s proposal concerns an additional 770 million RINs above the previously projected 2025 exempted obligation. EPA proposed dividing the amount across 2026–27 or allocating it entirely to 2027, with possible reporting-deadline adjustment. The hearing is November 4 and comments close December 4. Treating all 1.76 billion exempted RINs as incremental certain demand confuses the additional quantity and legal status. [S15]

Eligibility, geography and substitutions

Section 45Z is a separate production-tax incentive. The statutory extension runs through qualifying sales by December 31, 2029, with North American feedstock-origin requirements for relevant production. February implementation regulations were proposed; subsequent guidance supplies emissions-rate instructions. Statute, proposal and issued guidance have different authority. No uniform credit value applies to Bunge’s entire worldwide crop network. [S49][S50]

Eligible origin can matter as much as the unadjusted commodity price. A qualifying North American oil may be more valuable to a producer than a cheaper excluded input. Excluded material can move elsewhere, changing global basis relationships. Used cooking oil, animal fats and other eligible feedstocks remain substitutes. The company may gain from origination, documentation and refining while the producer receives the direct tax credit.

Low-cost foreign labor is not the principal threat; crop costs, currencies, export taxes, energy, freight and competing capacity can undermine higher-cost assets. Multiple origins reduce dependence on a single harvest but add exposure to trade controls and political intervention. European traceability requirements also affect access and operating cost: the Council’s current timetable applies to larger operators from December 30, 2026. Segregation and documentation may consume capital even when buyers pay no premium. [S46]

ADM’s Q2 Ag Services & Oilseeds profit increased to $867 million from $379 million, with approximately $100 million favorable timing. Its commentary identifies renewable obligations, elevated energy and execution. This corroborates an industry upswing and contradicts attributing every dollar of BG improvement to Viterra. Peer evidence is a control for common conditions, not a mechanically comparable margin benchmark. [S19]

Verdict: Demand supports activity; capacity, substitution, local geography and policy determine rent capture. Bunge’s best durable protection is efficient corridors and operating flexibility. Permanent global scarcity spreads are a much weaker underwriting assumption.

Competitive Position

Bunge’s advantage is coordination across origination, transformation, transport, distribution and finance. A combined route can cost less, operate more reliably or handle a disruption better than separately negotiated stages. Viterra adds crops, origins and customer connections to that system. The advantage is financially meaningful only if procurement basis, useful utilization, freight, losses or service deteriorate without it. Counting assets establishes scale; measuring contribution on capital establishes whether scale creates value.

The quarter’s evidence

Q3 soybean processed volume declined from 12.139 million to 11.745 million tons, approximately 3.2%, while adjusted EBIT increased from $478 million to $565 million, approximately 18.2%. Softseed volume increased from 3.129 million to 3.606 million tons, approximately 15.2%, and adjusted EBIT increased from $275 million to $329 million, approximately 19.6%. Both periods include most of the combined company. Portfolio changes, including ViOil, still prevent labeling the comparison clean organic growth. [S2] (segment results)

Dividing value-chain EBIT by processed tons gives indicative soybean contribution of approximately $48 versus $39 per ton and softseed contribution of approximately $91 versus $88. These calculations are diagnostics, not disclosed crush margins. The numerator includes origination, refining and other activities while the denominator captures processing. The improvement asks a useful question about contribution relative to physical scale; it does not isolate a plant cost advantage.

Disconfirming evidence is equally clear. Tropical Oils and Specialty Ingredients fell from $51 million to $16 million adjusted EBIT, while Grain Merchandising and Milling declined from $120 million to $87 million. Soybeans and softseeds supplied approximately 90% of Q3 adjusted segment EBIT. A broader physical footprint has therefore not produced equally diversified current profit. The network can improve oilseed economics while leaving shareholders heavily exposed to the oilseed balance. [S2]

Management cites having the right soybeans during western North American old-crop tightness, sourcing wheat into Brazilian mills from alternative origins, using grower relationships to expand cotton origination and coordinating freight. These examples describe mechanisms that could create recurring commercial value. They remain management attribution without a complete bridge separating incremental profit, market conditions and capital required. [S4]

The stronger test follows similar assets through different conditions. Better relative utilization during a regional shortage supports routing flexibility. Retained contribution after regional basis normalizes supports recurring execution. Higher profit accompanied by disproportionate extra inventory is more ambiguous: it can represent a normal return on newly financed capital. Public segment reporting does not yet separate those explanations well enough for full commercial-synergy capitalization.

Shared barriers and customer choice

Competition depends on delivered price, origin access, specification, reliability, financing and risk execution rather than broad proprietary product scarcity. ADM, Cargill, Louis Dreyfus, Wilmar and COFCO possess substantial overlapping capabilities. Global scale protects incumbents from an entrant attempting to recreate everything; it does not prevent serious rivalry among existing networks. A local bottleneck can create bargaining power without establishing a global winner-takes-all industry. [S5][S47]

Canada’s review also qualifies management’s description of limited transaction overlap. The combination was complementary across many global activities, yet regulators identified meaningful overlap around specific Canadian plants and customers. Both observations can be true at different geographic resolutions. The investment model must retain the local evidence and the remedies that constrain the resulting bargaining benefit. A global presentation is insufficient to establish competition in each catchment. [S47][S48]

Switching costs are generally low for commodities and moderate where qualification, formulation, traceability or dedicated logistics make substitution costly. A food customer may need testing and production trials before changing an ingredient. A fuel customer needs suitable specifications and records. These frictions support repeat demand but also slow a new facility’s commercialization. Qualification is a potential source of relationship value and a barrier Bunge itself must cross before earning it.

Consumer brands have limited relevance to consolidated economics; institutional reliability, food safety and execution matter more, although selected milling and specialty brands have value. Management’s Rosa Branca example describes extending a regional retail brand over the enlarged Brazilian milling footprint. It does not establish consolidated branded pricing power. Incremental demand must cover marketing, distribution and operating capital before the extension creates value. [S4]

Savings, resilience and moat depth

Management’s eventual cost-synergy objective is $350 million, with slightly more than $200 million annual savings expected in 2026. A target, an exit run rate and a realized annual contribution are different measures. Actions completed late in a year can produce a large run rate with little current-year benefit. Savings also require implementation expense, systems work and possible retention costs. [S4][S10]

Net savings can protect volume rather than appear entirely as higher profit. A lower-cost processor may bid more competitively for crops or offer better customer terms when spreads narrow. That can preserve returns and customer access, but it limits the savings capitalized as a permanent standalone earnings increment. Gross cost reduction is strategically useful even when competition transfers part of the benefit to others.

ADM is a control for shared processing conditions, with different carbohydrate, ethanol, nutrition and Wilmar economics. AAK offers a specialty reference rather than a whole-company comparable; private merchants lack continuously traded valuation anchors. Bunge’s 8.8% inventory-adjusted ROIC cannot be ranked mechanically against ADM’s 7.8% adjusted ROIC because inventory, taxes, outside ownership and capital definitions differ. [S3][S19]

The relevant moat claim is relative resilience on a complete capital base. If the enlarged company maintains utilization and returns better than capable peers in a weak region, the network has proved economic value. If returns decline equally while the capital base remains larger, shareholders mainly acquired greater scale and more financing needs. One supportive quarter cannot resolve that full-cycle comparison.

Verdict: The network advantage is credible, shared with capable rivals and strongest in particular corridors. Q3 supports improved capture; oilseed profit concentration, regulatory remedies and moderate returns prevent a conclusion that merger scale has created a deep group-wide moat.

Growth History and Forward Opportunities

The product outlook is constructive for oilseed throughput and eligible fuel feedstocks, while profit growth remains conditional on meal demand, procurement, competing capacity, policy and successful project ramps. Recurring food and feed demand supports utilization. Fuel policy can accelerate consumption but also stimulates competing supply and differentiates eligible origins. Growth in physical tons therefore needs its own return-on-capital test. [S16][S17][S18] (physical demand observations)

Historical revenue growth blends a commodity cycle, acquisitions and portfolio changes. The immediate opportunity is more attractive when framed as earning more from investment already funded. Customer-qualified output, yield, uptime and net contribution matter more than the number of announced projects. A company can end a construction cycle without ending its period of weak economic returns.

The identified 2027 bridge

On the latest call, management described approximately $0.50 EPS improvement from projects, $0.50 from additional cost synergies and $0.50 from commercial opportunities in 2027 relative to 2026. At an illustrative 194 million diluted shares and 25% tax, each $0.50 equals approximately $129 million pretax contribution. This is analyst arithmetic, not EBIT guidance; ownership, financing and jurisdiction affect the actual translation. [S4]

Morristown has moved from commissioning to customer qualification. Destrehan’s added processing line and barge unloader began operating in October. Westzaan is expected to start in Q1 2027, and Avondale’s refining capabilities are included in the project discussion. Destrehan operates through the Chevron joint venture; Bunge receives half its earnings. Venture-level capacity cannot be valued as wholly attributable group economics. [S4]

Commercialization has several gates. Plants must achieve physical reliability, produce specified quality, obtain customer acceptance and deliver repeat profitable orders. Fixed costs, depreciation and interest can begin before useful utilization. Working capital may rise as feedstock and saleable product accumulate. A project can pass its construction milestone while failing the shareholder return test for several further quarters.

Management described the projects as approximately neutral at the 2026 operating-profit level overall, with a modest drag mainly through interest. Removing an assumed large startup loss and then adding the full 2027 estimate would therefore exaggerate improvement. The incremental contribution already describes movement from the present operating base. [S4]

The prospective categories were also included in March’s approximately $13 framework. They must be mapped into that construction rather than stacked on top. The commercial estimate appears larger than the earlier approximately $0.35 EPS category, but timing, definitions and incremental opportunities are not fully reconciled. The correct treatment is an open bridge, not selecting the largest number from every presentation.

Financing, smaller assets and the next capital cycle

Investor Day assumed $550–$575 million net interest at normalized working capital. Current guidance is $640–$670 million. The $92.5 million midpoint gap is approximately $0.36 per share after an assumed 25% tax at 194 million shares. Different frameworks need not converge immediately, but lower financing expense is a substantive assumption in realizing the earlier earnings construction. [S2][S8]

The $105 million IFF acquisition adds soy-protein, lecithin and related assets. Preliminary allocation included $60 million PP&E, $48 million inventory, $8 million intangibles and $1 million goodwill, alongside liabilities. The small premium reduces one kind of acquisition risk; it does not establish profitable demand. Specialty commercialization still requires acceptance and adequate utilization, with current segment weakness providing a direct counterweight to optimistic product narratives. [S1]

Portfolio exits can release capital. Brazilian sugar mills carry approximately $383 million expected consideration and European spreads approximately $239 million, subject to adjustments and closing. The European transaction is now expected in 2027. Proceeds are not current cash, and sold earnings and retained obligations must be removed or preserved consistently. An impairment is still an allocation loss even when disposal simplifies the remaining business. [S1]

The analytical base assumes total capex falls after major projects finish. Maintenance, safety, compliance and productivity spending continue. Some expenditures described as growth may be necessary to preserve competitive contribution. Consequently, simply dropping spending to the management-defined sustaining line can overstate future cash. The relevant reinvestment budget is the amount needed to preserve the cash earnings being capitalized.

Management’s $15-plus 2030 ambition organizes further growth and capital allocation but does not establish an earned terminal result. New projects must include operating capital, startup, taxes and dilution as well as construction. The best next phase would increase contribution from deployed assets before committing to another large expansion whose returns depend on the same policy-supported spreads.

Verdict: Operating milestones and the next-year bridge make growth more concrete. Recognition should remain staged because customer acceptance, net savings, financing and recurring cash returns still separate commissioned capacity from value creation.

Financial Quality

Five years of results and the acquisition perimeter

Viterra entered consolidation on July 2, 2025. FY2025 therefore includes approximately six months of the acquired company and nine-month 2025 approximately one quarter. Reported 2026 revenue and volume growth are not comparable organic growth. The annual statement series below uses filing values rather than substituting standardized per-share calculations. [S1][S5][S6][S7] (current filing)

$ billions except EPS and SBC 2021 2022 2023 2024 2025 9M 2026
Revenue 59.152 67.232 59.540 53.108 70.329 69.706
Gross profit 3.363 3.682 4.845 3.393 3.409 3.78
Parent net income 2.078 1.610 2.243 1.137 0.816 1.064
GAAP diluted EPS, originally reported 13.45 10.52 14.87 7.99 4.91 5.45
Management adjusted EPS 12.93 13.91 13.66 9.19 7.57 6.38
Operating cash flow (2.894) (5.549) 3.308 1.900 0.844 (2.302)
Cash capex 0.399 0.555 1.122 1.376 1.723 1.163
SBC, $ millions 61 65 69 65 73 70

The EPS series is not a newly recast continuing-operations series; later comparative filings can differ slightly. Early common EPS also reflects preference dividends and participating-security conventions. Nine-month results are not annualized. The adjusted series follows management’s reconciliations and does not represent cash. Historical statements and the current release supply complementary accounting and normalized views. [S2][S5][S7][S31][S32]

Gross margin reached approximately 8.1% in 2023, then fell to 6.4% in 2024 and 4.8% in 2025. The enlarged 2025 revenue base produced almost unchanged gross profit. That is powerful evidence against interpreting transaction-driven sales growth as economic improvement. The merger also changed corporate costs, debt and weighted shares, so neither revenue growth nor a trough GAAP P/E describes the combined earnings opportunity adequately.

Earnings are recovering from the merger-affected 2025 trough but remain below the exceptional 2021–23 adjusted cycle; the combined company has not demonstrated its floor through a full weak-spread year. Favorable external conditions and peer results support current earnings but weaken attribution of the whole recovery to integration. A larger earnings floor requires evidence during normalization, rather than comparison only with the most burdened transaction year.

Segments and adjustment quality

Adjusted EBIT, $ millions Q3 2025 Q3 2026 9M 2026
Soybean Processing and Refining 478 565 1,387
Softseed Processing and Refining 275 329 779
Tropical Oils and Specialty Ingredients 51 16 90
Grain Merchandising and Milling 120 87 198
Total segments 924 997 2,454
Corporate and Other (167) (151) (382)
Adjusted Total EBIT 757 846 2,072

All EBIT measures here are non-GAAP. Company-defined Total EBIT is also not a conventional consolidated GAAP operating-income line: its reconciliation is parent-oriented and adjusts outside-owner economics. Adjusted EBITDA starts with consolidated net income. Those ownership conventions matter for enterprise valuation and prevent an automatic substitution of one numerator for another. [S2][S3]

Q3 continuing GAAP EPS of $1.64 reconciles to $2.56 adjusted through $0.28 adverse timing and $0.64 specified charges. Nine-month timing was favorable $0.12, with adverse specified charges of $1.05. The cumulative reversal supports treating some derivative volatility as timing; it does not validate every other exclusion. Disposal losses, integration costs and conflict exposure remain economically consequential even when removed from a continuing forecast. [S2]

Accounting is understandable for a hedged physical merchant but not inherently conservative: fair-value estimates and timing adjustments are necessary, while excluded integration costs and disposal losses require separate economic recognition. Normalization should follow the transaction, cash effect and likely recurrence. Forecasting ongoing profit can justify excluding an impairment, while acquisition assessment must retain the capital lost. Treating the same charge consistently across those two questions is more useful than preferring either GAAP or adjusted earnings categorically.

Returns with matched inventory treatment

Current profitability is moderate: company-defined ROIC is 7.0% and inventory-adjusted ROIC is 8.8%; both are non-GAAP measures. The former uses approximately $2.304 billion adjusted after-tax return over $33.099 billion average adjusted capital. The latter uses $1.829 billion over $20.784 billion. Management’s stated 6.0% WACC is a company estimate, not an independently established equity hurdle. [S3]

The inventory adjustment removes $12.315 billion average merchandising RMI and deducts an approximately $603 million pretax financing allowance at a 4.90% debt cost. It is a matched construction, not simply removing inventory while retaining all related profit. The economic rationale recognizes that marketable crops differ from permanent plant investment.

The limitation is operational necessity. More inventory can be structurally required even when each crop parcel turns quickly. Excluding it can improve an operating-asset ratio while shareholders still finance the system. The historical inventory-adjusted return fell from 25.5% in 2022 to 20.0%, 12.6% and 8.1% in 2023–25, before reaching 8.8%. The less inventory-adjusted measure fell from 15.8% to 14.6%, 10.1% and 6.9%, then 7.0%. Peak scarcity returns were real; their erosion challenges a permanent-rent thesis. [S3]

Capital structure and liquidity

$ billions except ending shares 2023 2024 2025 Sep. 2026
Total assets 25.372 24.899 44.528 49.66
Cash 2.602 3.311 1.135 0.524
Inventories 7.105 6.491 13.198 16.624
Funded debt excluding operating leases 4.882 6.238 14.051 16.746
Parent equity 10.851 9.913 15.904 16.296
Shares, millions 145.320 133.964 193.409 192.142

The latest cover count is 192.144 million on October 27. Ending shares are appropriate for current capitalization; weighted diluted shares govern EPS. Company Financials was used for profile, multi-period statements, ratios, enterprise-value fields and transcripts. Standardized values were reconciled to filings; incomplete September EV fields and cash-flow fields lacking capex were excluded. No precise historical valuation percentile is inferred from those incomplete resources. [S1][S5][S6]

The debt bridge is $16.746 billion funded debt less $524 million cash, or $16.222 billion cash-only net debt. Deducting $366 million qualifying investments gives $15.856 billion. Subtracting $10.315 billion RMI credit and adding $1.620 billion receivables funding produces $7.161 billion adjusted net debt: 1.9 times $3.728 billion trailing adjusted EBITDA. Before RMI credit, net debt is approximately 4.25 times that denominator. These ratios answer different questions. [S3]

The 70% credit uses $14.736 billion RMI including $40 million held for sale; the inventory note excludes that disposal amount. Reducing the assumed credit to 50% raises adjusted leverage to approximately 2.71 times without new borrowing. This is an analyst sensitivity, not an agency forecast or covenant calculation. It measures definition risk separately from actual debt growth.

Undrawn committed revolvers were $8.515 billion. Issued commercial paper of $2.073 billion requires at least equivalent same-day unused committed backing. Reserving that support leaves approximately $6.442 billion for additional drawings while paper stays outstanding; cash and qualifying investments add approximately $890 million. Revolvers can refinance paper, so this is a conditional stress bridge, not a declaration that reserved facilities are legally inaccessible. Unissued paper authorization is not independent additional committed funding. [S1][S6]

Cash, collateral and additional obligations

The business is highly working-capital-intensive and materially fixed-capital-intensive: crop inventory, collateral and supplier funding sit alongside processing plants, logistics and recurring capex. Saleable collateral improves financeability; it does not eliminate the capital needed to operate. The distinction matters most when activity and crop prices increase together.

Net income diverges from operating cash because inventory, supplier advances, margin deposits, customer advances and settlement timing move cash independently of reported profit. Nine-month inventory changes used $3.559 billion, supplier advances $386 million, margin deposits $379 million and reduced sales advances $330 million. Payables and accruals supplied a partial offset. CFO less total capex was negative $3.465 billion. [S1]

Trailing CFO was negative $955 million; reconstructed trailing capex was approximately $1.701 billion, producing negative $2.656 billion on that definition. Management’s $1.947 billion discretionary cash flow removes working-capital changes and deducts only sustaining capex. The measures are not contradictory: one describes current full funding needs and the other a defined allocation capacity before operating-capital movements and growth spending. [S3][S5][S44]

Historical comparisons need a classification bridge. In 2021, $5.234 billion beneficial-interest proceeds less $177 million related payments offset raw CFO of negative $2.894 billion, giving approximately $2.163 billion before capex. In 2022, $6.824 billion collections offset negative $5.549 billion CFO, giving $1.275 billion. A November 2022 move from deferred-purchase-price to pledge structure changed classification. The correction does not eliminate genuine operating-capital volatility. [S7][S31][S32]

Level 3 RMI declined from $2.851 billion in June to $2.596 billion in September but remained above $1.407 billion at year-end. Transfers out exceeded transfers in during Q3, so the decline cannot establish better physical liquidity by itself. Unobservable freight and location inputs, chiefly in interior Brazil and Canada, differ from proof of impairment. Related derivatives and commitments must be considered before interpreting gross inventory marks as unhedged earnings. [S1][S9]

Economic obligations beyond funded debt include receivables funding, operating leases, guarantees, residual-value commitments, indemnities and legal or tax contingencies. Operating lease liabilities total $1.528 billion outside held-for-sale balances. Maximum guarantees are $484 million against $17 million recorded; indemnities have $125 million recorded against $1.6 billion maximum. Brazilian asserted ICMS and PIS/COFINS claims are $160 million and $598 million. Maximum and asserted amounts are not expected-loss estimates and should not simply be summed. [S1]

The $2 billion receivables program ends in 2031, while individual purchaser commitments expire in December 2026 subject to extensions. Sold receivables were $1.620 billion and pledged unsold receivables $461 million, up from $299 million in June. Sales transfer meaningful risk, but growing pledged support complicates a simple improving-funding narrative. Collateral, renewal terms and loss limits deserve more attention than the legal program’s distant final date. [S1][S9]

Verdict: Earnings recovery is supported, cash conversion remains weak and returns are moderate. Marketable crops and committed credit support financeability. Consistent capital definitions, collateral behavior and eventual cash realization determine how much improvement reaches shareholders.

Capital Allocation

Conventional free cash flow is currently negative; management allocates from adjusted funds from operations after sustaining capex while funding operating-capital needs separately. Nine-month adjusted FFO of $2.008 billion less $410 million sustaining capex gave $1.598 billion discretionary cash flow. Dividends of $414 million, growth and productivity capex of $753 million, the $105 million acquisition and $249 million repurchases left $77 million in that framework. The bridge explains management’s choices but does not remove the operating cash deficit. [S3] (allocation reconciliation)

Management targets at least 50% of discretionary cash flow returned through dividends and repurchases across the cycle. This is a policy based on a defined non-GAAP measure, not a commitment to distribute half conventional free cash flow every year. It permits timing discretion. The policy creates value only if sustaining needs and the funding capacity required for downturns are realistically measured. [S8]

Acquisitions and reinvestment

Viterra is strategically coherent, but its financial return remains unproven against $10.617 billion accounting consideration and the wider integration and funding commitment. Sellers received approximately 65.6 million shares valued at $5.340 billion and $1.880 billion cash. Repayment of $3.554 billion specified debt and a negative $157 million settlement produced accounting consideration. That is not a complete enterprise-return denominator: acquired cash, assumed debt and subsequent investment need separate treatment without double counting. [S1]

Final Viterra goodwill was $2.880 billion, including a $574 million measurement-period increase mainly associated with asset valuations. The residual largely reflects synergies and workforce value and is not expected to be tax deductible. Higher goodwill does not alone prove overpayment. It increases the importance of future cash contribution in supporting the acquisition value. [S1][S9]

EPS accretion is an incomplete scorecard. Financing, favorable spreads, repurchases and adjustments can raise EPS while returns on total committed capital remain ordinary. The appropriate numerator includes incremental after-tax cash earnings after integration, sustaining investment and losses. The denominator includes consideration, relevant obligations and incremental operating capital. Public reporting does not isolate a clean Viterra cash IRR, so financial success remains unscored.

The smaller IFF acquisition has less absolute premium risk but still needs qualification and utilization. Portfolio exits can simplify operations and reduce financing, while any impairment belongs in the allocation history. Canadian investment and operating commitments also constrain freedom to close or redeploy acquired assets. The shareholder scorecard must include those obligations, rather than measuring acquisition economics solely against gross synergies. [S1][S48]

Current restraint has value because already-funded assets are approaching contribution. Every additional large project would extend the period during which cash is committed before returns are observable. Avoiding such commitments can improve cash generation even without a new operating initiative. The opportunity cost is foregoing attractive growth; management should resolve that tradeoff with through-cycle returns and liquidity, rather than current spread extrapolation.

Repurchases, issuance and insider evidence

Bunge repurchased 1.966 million shares for $249 million in Q2 at a reported $126.85 average, bought none in Q3, and reduced ending shares by only 1.266 million from year-end after issuance offsets. The latest price is approximately 23.8% below the final tranche’s purchase average. That mark-to-market result does not establish intrinsic-value destruction, but it shows limited price protection from the most recent deployment. [S1][S9][S20]

The completed $2.7 billion authorization bought 28.383 million shares, implying approximately $95.13 average cost using rounded spending. The current price is modestly higher. A complete allocation return would include financing costs, dividends and alternative uses of cash. The new $3 billion authorization was wholly unused at September and has an indefinite term. Authorization is optionality; assumed repurchases need an available-cash and price model. [S1]

Approximately 0.70 million shares of issuance offsets separate gross purchases from the net ending-share reduction. That gap is not wholly insider issuance. Awards, option exercises, tax withholding and other movements need their own reconciliation. A repurchase authorization’s face amount is not equivalent to net ownership accretion, particularly after a transaction that issued a large seller stake.

Verified insider receipts are compensation-related, while merger shares were acquisition consideration; neither establishes open-market insider conviction buying. Nine-month SBC was $70 million. Inspected September filings show 253 units for Julio Garros and 992 for Greg Heckman under dividend features, transaction code A. Those are not code-P purchases. No exhaustive five-year insider census was established, so a claim that no officer bought or sold during that whole period would exceed the evidence. [S1][S27][S28]

Distributions, governance and pay

The approved annual dividend is $2.88 per share in four $0.72 installments, about 30% of the current guidance midpoint; earnings coverage is comfortable while cash coverage depends on the funding cycle. Installments run from Q2 2026 through Q1 2027. At the current share count the annual requirement is roughly $553 million. Approval of an annual rate should not be confused with calendar-year payments. [S1][S2]

Director compensation combines cash and equity, while executive incentives emphasize adjusted profit, cumulative EPS, adjusted ROIC and relative shareholder return. Nonemployee directors receive $150,000 annual cash retainers and $200,000 equity awards, plus leadership fees. Regular 2025 executive long-term awards were 60% performance units and 40% time-based units. Performance measures split cumulative EPS and average adjusted ROIC equally, with a relative-TSR modifier. [S11]

The 2023–25 performance award paid 59% of target, indicating that weaker outcomes affected compensation. Adjustments for Viterra dilution and methodology changes complicate interpretation. CEO reported total compensation was approximately $18.95 million in 2025 versus $16.81 million in 2024. Grant-date accounting compensation is not realized compensation, and increased organizational scale can influence benchmarking before acquisition returns are proven. [S11]

A separate integration award measures cumulative run-rate cost synergies during 2026–28. Its risk lies in metric design: gross annualized savings can diverge from net cash value after implementation, inflation and dis-synergies. Regular return and shareholder-performance metrics provide a counterweight without eliminating that divergence. [S12]

Management’s incentives favor integration, scale, credit access and per-share results, while adjustment discretion and the special synergy award require independent scrutiny of net cash returns. This is a governance interpretation, not evidence of manipulation. Seller board representation can add expertise, while making transparent treatment of related-party dealings and minority shareholders particularly important.

Verdict: Allocation has a coherent strategy and current financing restraint, but the defining acquisition remains financially unproven. Net ownership gains and cash returns on all committed capital are more persuasive than gross savings, authorization size or acquisition accretion.

Changes and Headwinds — Last Two Years

The business environment changed materially through Viterra consolidation, renewable-fuel rules, shifting trade routes, project commissioning and higher working-capital requirements. The network offers more responses to disruption while carrying a larger fixed and financial commitment. Standalone comparisons must preserve the acquisition perimeter. Greater reported scale does not independently establish better execution or a less cyclical enterprise. [S1][S5][S13] (current operating discussion)

Guidance and the quality of the change

The 2026 adjusted EPS range began at $7.50–$8.00, increased to $9.00–$9.50 after Q1, rose to $9.25–$9.75 after Q2 and remained there after Q3. The latest unchanged range masks a mix change: soybean expectations are slightly lower, specialty lower, grain higher and softseed unchanged. Net interest is now $640–$670 million, capex toward the high end of $1.5–$1.7 billion and adjusted tax 23%–25%. [S2][S10][S45]

Subtracting nine-month adjusted EPS of $6.38 from annual guidance implies approximately $2.87–$3.37 for Q4. This is approximate arithmetic because annual and quarterly weighted shares and rounding differ. It should not be described as precise quarterly guidance. Management said the implied reduction against its previous Q4 expectation largely reflected interest and taxes, while operating profit was approximately flat against that earlier expectation. That differs from forecasting a sequential operating decline. [S4]

External conditions set much of the available spread, while internal procurement, utilization, integration and routing determine Bunge’s capture. ADM’s parallel improvement confirms the shared component. Better BG soybean earnings on fewer tons support improved capture, but cannot isolate execution from a richer realized spread. The useful comparison is relative contribution and capital through changing conditions, rather than assigning all improvement to either industry or management.

The working-capital commentary is an important negative update. Management attributed most of the increase to prices, with smaller volume effects, and expects elevated needs through year-end and likely early 2027. It links higher capital use to earnings opportunity. That is a plausible commercial explanation, not an independently demonstrated return on the incremental funds. Shareholders need the subsequent contribution and release bridge to validate it. [S4]

Transactions, facilities and leadership

Important facility and leadership changes include Destrehan commissioning, Morristown qualification, Westzaan’s expected Q1 2027 startup, delayed European disposal proceeds and announced legal and accounting succession. These changes move the company from building assets toward proving commercial utilization, while integration and controls remain demanding.

Ignacio Walker is due to become chief legal officer on November 9, with Joseph Podwika becoming an adviser before planned November 2027 retirement. Matt Simmons plans to retire as controller and chief accounting officer in March 2027, with Richard James succeeding him in April. The accounting succession filing explicitly states there was no disagreement behind the departure. Those are orderly announced transitions, not evidence of an accounting dispute. [S24][S25]

Brazilian mill terms are now disclosed and European spreads completion has slipped into 2027. Timing matters because prospective proceeds cannot reduce current borrowing. Disposal also removes an earnings stream and can retain indemnities. The correct update adjusts cash, earnings and obligations together rather than treating a gross announced receipt as free deleveraging. [S1]

Regulation, conflict and reporting

The policy backdrop combines supportive obligations with unfinished implementation. October reallocation remains proposed, 45Z differentiates feedstock eligibility, Canadian merger conditions impose obligations and European traceability rules approach application. These are economically different mechanisms: some stimulate end demand, some divide eligibility and others constrain merger rents or increase costs. A single policy optimism factor cannot capture them all. [S15][S46][S48][S49]

Conflict creates profitable rerouting and direct losses simultaneously. Q3 included Ukraine-related charges. Crop quality, currencies, farmer selling and US–China trade timing affect origin economics. Political purchase commitments are not realized group margins; volumes, timing, basis, freight and funding determine what Bunge retains. Management’s route examples help identify monitoring variables, without validating a guaranteed geopolitical windfall. [S2][S4]

No material change in principal recognition policies was identified; consolidation, purchase accounting, segment presentation and forthcoming standards drive comparability. September disclosure controls were reported effective at reasonable assurance, with phased Viterra control integration continuing. The environmental-credit standard is effective for annual periods beginning after December 15, 2027 and remains under evaluation. It does not supply a disclosed current earnings benefit. [S1]

Verdict: Recent evidence improves the specificity of operating gains and weakens expectations of rapid funding relief. Higher interest, delayed proceeds and continuing systems integration constrain the cash benefit from unchanged headline guidance.

Risk Analysis

The principal risks interact. Weaker spreads can reduce earnings while collateral and crop inventories still need funding. Borrowing costs rise, distributions narrow and the equity multiple contracts. A model that treats these as independent average losses understates correlated stress. The likelihood assessments below are analyst judgments, not statistical probabilities.

Risk Likelihood Impact Evidence basis Mitigation or offset Monitoring signal
Capacity catches demand High over cycle High Supply and crush expansion [S17][S18] Multiple origins and cost control Meal realization, regional spreads, utilization
Operating capital remains elevated High near term High Cash use and latest outlook [S1][S4] Marketable crops and credit Inventory, ordinary debt, collateral
2027 benefits are late Medium High Estimated contributions and qualification [S4] Several projects operating Qualified sales, utilization, net benefit
Policy timing or eligibility disappoints Medium High Reallocation proposal and tax rules [S15][S49] Food/feed demand and origin flexibility Final rules, credits, physical inputs
Inventory realization weakens Low–medium High Location and freight estimates [S1] Markets, hedges, diversified routes Aging, discounts, movement delays
Short-term funding access tightens Low–medium High December purchaser expiry and CP [S1] Extended revolvers [S23] Renewals, committed headroom
Specialty utilization disappoints Medium–high Medium Weak Q3 contribution [S2] Qualification and product capability Repeat orders and segment cash profit
Conflict or counterparty failure Medium High locally War charges and credit exposures [S1][S2] Risk limits and route diversity Damage, provisions, settlement delays
Legal or tax payment Low–medium Medium–high Claims and contingent obligations [S1] Reserves and defenses Judgments and reserve changes
Gross savings fail to become net value Medium Medium–high Targets and award design [S4][S12] ROIC and TSR metrics Costs, dis-synergies and capital
EPS and valuation contract together Medium High Cyclical returns and drawdowns [S3][S20] Lower starting multiple Sustainable contribution and cash

A material stock decline could follow weaker crush spreads, delayed projects or synergies, adverse policy timing, persistent financing needs or a lower multiple on normalized earnings. At 194 million diluted shares and an assumed 25% tax, each $100 million pretax contribution change is approximately $0.39 EPS. A few hundred million dollars of spread normalization can offset much of the proposed self-help.

The asymmetry of working capital deserves particular attention. Higher crop prices can require more funding before profit improves. Falling prices can release cash, yet severe basis dislocation can create losses and margin calls before inventory sells. Price direction alone is therefore an inadequate stress model. Available credit, delivery routes and the timing of settlement matter alongside ultimate collateral value.

An illustrative $500 million pretax operating shock reduces EPS by about $1.93 under those simplified assumptions. An additional $2 billion operating-capital requirement funded at 6% adds $120 million pretax interest, or about $0.46 EPS. The interest is additional only if absent from the first shock. This is a sensitivity, not a forecast; its purpose is to show how operations and finance can reinforce each other without double counting.

Inventory funding does not automatically imply an economic loss. Selling crops can repay debt. The more difficult question is whether inventories can decline without reducing profitable activity, and whether they move at acceptable basis when liquidity is most valuable. Replenishment, transport bottlenecks, customer delays and collateral requirements can keep enterprise cash committed even when individual crop transactions ultimately settle profitably.

Catastrophic investment loss would most plausibly require correlated basis or counterparty losses, collateral demands, impaired inventory movement and restricted financing access. An ordinary crush downturn alone is a less persuasive enterprise-threatening pathway. A combined shock could trap crops at unfavorable locations, impair customers or suppliers, trigger cash margin and close short-term credit markets. Useful operating assets can retain enterprise value while creditors or emergency equity issuance absorb much of the shareholder claim. [S1][S5] (principal risk disclosures)

Derivative notional amounts are not expected losses. Gross derivative assets are not necessarily unrestricted collateral. Netting rights, margin terms, delivery obligations and physical offsets determine risk. The relevant liquidity stress is cash needed before settlement, together with realizable assets under actual transport and contractual constraints. A favorable eventual economic hedge does not eliminate an interim cash requirement.

Total loss appears unlikely, but its plausible path is liquidity exhaustion and operational failure that transfer enterprise value to creditors; public evidence cannot support a defensible numerical probability. The more ordinary permanent-loss mechanism is years of inadequate returns on the enlarged capital base. The business can remain essential and solvent while shareholders experience poor compounding and a persistent discount.

Verdict: Severe cyclical equity loss is more plausible than insolvency. The ordinary hazard is that operating benefits are delayed, competed away or absorbed by finance. The tail hazard combines an inability to fund the system with an inability to move its physical assets.

Valuation Discussion

Capitalization and matched enterprise definitions

At $96.64 and 192.143784 million shares, equity value is approximately $18.569 billion. Adding $16.746 billion funded debt, deducting $524 million cash and including $1.506 billion noncontrolling equity plus $78 million redeemable noncontrolling interest produces approximately $36.375 billion enterprise value. Deducting another $366 million qualifying investments gives $36.009 billion. The conventions are explicit; they are not identical definitions of net debt. [S1][S20] (balance-sheet inputs)

The investment-adjusted figure divided by $3.728 billion trailing adjusted EBITDA is approximately 9.7 times. Adding $1.620 billion derecognized receivables funding gives approximately $37.629 billion, or 10.1 times. Replacing ordinary net debt with management’s $7.161 billion adjusted net debt gives approximately $27.314 billion, or 7.3 times. These are alternative diagnostics, not independent evidence that the equity is cheap. [S3]

The denominator includes consolidated outside-owner economics, making inclusion of noncontrolling claims directionally appropriate. Parent-oriented EBIT needs a different ownership comparison. Operating leases are excluded here while rent remains expensed; lease-inclusive EV requires a matched earnings treatment. Affiliate investments introduce additional imperfections. Precision to a tenth of a turn should not be mistaken for a fully restated comparable-company model.

Inventory credit must not be combined with a separate valuation of the same inventory release. Likewise, recognizing economic receivables funding does not imply every sold receivable is full-recourse bank debt. Contractual collateral and loss limits matter. Consistency is more valuable than choosing the convention that produces the lowest multiple.

Earnings, assets and peers

The price equals 10.2 times the $9.50 guidance midpoint, 11.5 times management’s $8.38 trailing adjusted EPS and 8.8 times the analyst’s $11 sustainable estimate. The trailing measure sums four quarterly adjusted EPS figures rather than reconstructing one weighted-share annual period. At the September reference price, the same guidance midpoint implied 13.1 times. [S2][S3][S20]

Parent book is approximately $84.81 per share. Removing separately reported goodwill and other intangibles gives approximately $65.85 tangible book, before small held-for-sale refinements. The resulting multiples are 1.14 and 1.47 times. Neither is a liquidation floor. Inventory carries basis and location risk, plants can be specialized or redundant and goodwill has no separate sale value.

ADM’s $76.91 close equals approximately 14.3 times its latest verified adjusted guidance midpoint of $5.375. BG’s guidance multiple is about 29% lower. Different segment mix, funding, affiliate interests and accounting history limit interpretation; ADM’s verified outlook is also older. Without a matched current enterprise and return reconstruction, the full relative discount cannot be treated as mispricing. [S19][S29]

Own-history P/E is particularly vulnerable to cycle errors. A peak-earnings denominator can make shares appear cheapest when profits are least sustainable; merger charges can create the opposite impression. Changes in capital, shares and the asset perimeter further impair simple historical percentiles. The defensible historical observation is that earnings and returns have varied widely, not that one unreconstructed percentile establishes a precise valuation opportunity.

Management’s prospective construction

March framework category Approximate EPS Economic status
Then-current guidance midpoint 7.75 Starting forecast, since raised
Margin normalization 2.10 Cycle and policy assumption
In-flight projects 1.30 Future commercial contribution
Repurchases and debt reduction 0.50 Funding and allocation assumption
Original cost-synergy category 1.00 Target benefits
Commercial/network category 0.35 Target with limited separate attribution
Constructed baseline About 13 Prospective framework

Current guidance already contains improved margins and some integration. October’s increments map into the existing categories. Adding the guidance uplift and all newer estimates to the old total would count benefits twice unless a new contribution source is demonstrated. The framework’s normalized interest and processing-margin assumptions are not reported current outcomes. [S8]

A separate near-term arithmetic bridge is $9.50 current guidance plus approximately $1.50 management-estimated increments before changes in spreads, financing, taxes, mix and shares. It makes roughly $11 a plausible analytical reference, not formal 2027 guidance. The base case recognizes substantial next-year execution and partial eventual framework delivery; it does not award the whole management construction or assume all operating gains translate into cash. [S4]

Explicit operating scenarios

Analyst assumption Bear Base Bull
Illustrative annual revenue $85B $95B $100B
Parent-oriented adjusted EBIT proxy $2.45B $3.45B $3.95B
Corresponding margin 2.9% 3.6% 4.0%
Net interest $0.65B $0.65B $0.65B
Tax assumption 25% 25% 25%
Diluted shares 193M 191M 190M
Approximate adjusted EPS $7 $11 $13
Total annual capex $1.2B $1.2B $1.3B
Normalized working-capital investment $0.1B $0.2B $0.2B
Equity multiple 10.0× 11.5× 12.0×
Indicated equity value per share $70 $126.50 $156

These are assumptions, not consensus or statutory forecasts. The EBIT proxy approximates parent economics without reconstructing every minority, affiliate and jurisdictional tax line. Nominal revenue communicates scale but can change with crop prices without proportional profit. Small modeled share reductions require actual available cash; the authorization is not a financing source.

The bear assumes normalization overwhelms operating gains. The base assumes substantial savings and project delivery with operating-capital stabilization. The bull requires stronger conversion without adopting the whole 2030 ambition. The multiples retain cyclicality and reinvestment rather than awarding specialty-franchise economics. A harsher $7 EPS at eight times produces $56, illustrating why a ten-times bear multiple is not an absolute downside boundary.

Cash and terminal economics

Approximate base earnings of $2.1 billion plus $1.0 billion depreciation, less $1.2 billion total capex and $0.2 billion normalized working-capital investment yield about $1.7 billion equity cash before other cash/noncash and ownership adjustments. Interest is already in earnings and must not be deducted twice. Additional borrowing is excluded as a source of recurring economic distribution.

At a net capitalization rate equal to cost of equity less sustainable growth, that cash supports approximately $88 per share at 10%, $98 at 9% and $111 at 8%. Supporting $120 at 9% requires about $2.07 billion recurring equity cash at current shares. These are steady-state sensitivities, not detailed discounted cash-flow forecasts. They expose the terminal assumption hidden in an EPS multiple: earnings must become cash after continuing investment.

At 11.5 times earnings, the current quotation requires approximately $8.40 sustainable EPS; at ten times, about $9.66. The market need not believe all $13. It is correctly discounting unfinished execution and capital absorption. The fragile bearish assumption is that already-funded assets cannot improve the earnings floor; the fragile bullish assumption is that their contribution arrives without persistent financing or reinvestment offsets.

Verdict: Earnings valuation allows operating progress, while the conservative cash test is materially tighter. Capital conversion determines which view becomes economically relevant. A lower adjusted enterprise multiple cannot substitute for demonstrated shareholder cash.

Variant Perception

No independently verified current consensus distribution was available. The observable debate comes from management’s framework, analyst questions, peer results and the earnings required by the quotation. These sources support a reconstruction of competing views, not a claim that all institutions hold the same forecast. The distinction matters because identifying an apparent consensus error is easier than demonstrating one with attributable estimates. [S4][S8][S19] (latest analyst exchange)

The strongest bull case combines observed oil demand, a broader origin network, funded projects entering production and identifiable savings. It argues that the earnings floor has risen and that temporary capital absorption supports profitable throughput. The strongest bear case attributes much of the uplift to common industry conditions while integration increases fixed capital and finance needs. Specialty weakness and moderate returns provide concrete support for that skepticism.

The differentiated hypothesis is that operating improvement and capital absorption are both real. A lower earnings multiple can compensate for unfinished proof, but cannot transform undistributed profit into cash. The missing evidence is a consistent bridge from net benefits through capital employed and financing into cash available per share. That bridge would be more persuasive than another expansion of a gross savings target.

Investor questions and assumptions

Investor questions focus on working-capital release, project qualification, commercial-synergy definitions, contribution and energy-price sensitivity. Matthew Blair asked about cash absorption and South American margins; Ben Theurer about guidance and projects; Stephen Haynes about startup drag; Pooran Sharma about farmer selling and commercial gains; Heather Jones about merchandising; and Andrew Strelzik about energy and 2027. Their questions identify uncertainty, not independent confirmation of management’s answers. [S4]

Four assumptions carry the constructive case. Normal-crop earnings must exceed the old standalone-style reference. Savings and projects must produce net benefits without overlap. Operating capital must stabilize without material realization losses. Allocation must avoid another large commitment before returns improve. Each can fail separately, and correlated failure creates the larger equity downside.

The optimistic interpretation weakens if claimed synergies rise while comparable contribution and cash returns deteriorate with peers. The skeptical interpretation weakens if earnings remain above $10 through softer benchmark spreads, ordinary debt declines and both return measures improve. Another favorable quarter in the same industry regime does not settle either full-cycle proposition. [S2][S3][S19]

The factor model and price context

The October 30 factor model reports statistical exposures of approximately 0.465 to Energy-sector returns, 0.441 to OilPrice, 0.396 to NewDividend, 0.312 to Market, 0.285 to Materials-sector returns and 0.229 to CreditRisk. Growth is negative 0.203 and Quality negative 0.090. R-squared is 0.229 and adjusted R-squared 0.210. These are supplied internal diagnostics, not fundamental evidence or industry classifications. [S22]

Residual momentum is approximately 0.020, residual Sharpe negative 1.048 and residual volatility 0.254. Without the estimation window, units, coefficient uncertainty and complete specification, these values cannot establish an attractive reversal signal or quantify an earnings effect. Energy co-movement does not make Bunge an energy producer. Negative Quality exposure does not demonstrate accounting weakness.

The model explains less than one-quarter of return variation. The short-window ADM regression separately shows shared daily movement and greater cumulative BG weakness. Neither method identifies financing, integration or forced selling as the cause. There is no verified ownership-flow or short-interest basis for a squeeze thesis. The earlier Value-factor assertion is absent from the supplied snapshot and remains retired. [S20][S22][S29]

Testing inherited analytical lessons

The existing Bunge-specific requirement to reconcile inventory-adjusted leverage with ordinary debt and receivables funding remains supported. The current details narrow its interpretation: Level 3 inventory fell sequentially while pledged receivables increased. Neither a uniform deterioration narrative nor cash-equivalence treatment survives the full bridge. [S1][S9]

Research-capital sensitivities developed for software, equipment and pharmaceutical businesses do not justify numerical adjustments to BG. The useful principle is matched profit and capital treatment, applied here to inventory financing, acquisition capital, leases and outside ownership. Bank fair-value lessons likewise do not establish a bank-like capital problem at a physical merchant.

The securitization history supports a narrower transferable lesson: a documented classification change can dominate raw CFO comparisons without changing all underlying collections economics. Conversely, relative stock returns cannot prove commercial market-share transfer. Prices test common-factor explanations; customer, physical-volume and market-denominator evidence must establish product-market share. [S7][S32]

Verdict: The research advantage is decomposition of shared spreads, net execution and committed capital. The factor model and price residual provide risk context while cash and consistent returns determine whether the operating thesis is durable.

Fact vs. Interpretation

Reported outcomes, management forecasts and analyst assumptions require separate confidence levels. A non-GAAP result can be accurately reported without being equivalent to cash, and a plausible management explanation can remain unverified attribution. [S1][S2][S4] (reported reconciliations)

Statement Classification Correct treatment
Q3 continuing GAAP EPS was $1.64 Reported fact Accounting result [S1]
Q3 adjusted EPS was $2.56 Reported non-GAAP result Preserve reconciliation [S2]
Annual guidance is $9.25–$9.75 Management estimate Forecast, not earned income [S2]
Three 2027 increments total about $1.50 Management estimate Not formal annual guidance [S4]
Sustainable EPS is approximately $11 Analyst assumption Depends on execution, spreads and finance
The $13 framework is current earned EPS Unsupported interpretation Includes unfinished assumptions [S8]
2026 annual savings and exit run rate are identical Incorrect inference March showed $190M annual and $220M run rate [S8]
Nine-month CFO was negative $2.302B Reported fact Actual classified operating cash use [S1]
Raw historical CFO equals economic absorption Incorrect inference Reconcile investing-classified collections [S7][S32]
Adjusted leverage is 1.9 times Management metric Includes inventory credit and receivables funding [S3]
Lower Level 3 inventory proves improved liquidity Unsupported inference Transfers and marks also affect it [S1]
Additional exemption reallocation is final Incorrect legal status October action remains proposed [S15]
Higher oil use proves BG margin expansion Unsupported causal claim Demand and rent capture differ [S16]
September insider receipts were market purchases Incorrect classification Verified award-related code A receipts [S27][S28]
Energy exposure determines oil-price EPS sensitivity Unsupported causal claim The factor model measures co-movement [S22]

An impairment add-back can clarify continuing earnings while the loss remains part of capital-allocation history. Likewise, a plant milestone can establish progress without establishing its probability of full utilization or investment return. Consistent treatment across the income statement, capital base and cash bridge prevents those distinctions from disappearing inside a normalized figure.

Open Questions

The unanswered questions with the greatest investment value concern the earnings-to-cash bridge. Additional narrative about network breadth is less useful than data that separate prices, physical activity, net operating benefits and capital committed. Current disclosures leave the following material gaps. [S1][S4][S8] (management’s framework)

  1. How much operating capital is structurally required at unchanged crop prices and volumes, and how much current investment can reverse without reducing profitable activity?
  2. What integration cash spending remains for systems, retention, stranded costs and dis-synergies?
  3. How does approximately $0.50 commercial EPS improvement in 2027 reconcile to the original $90 million and approximately $0.35 category?
  4. Which utilization, quality, yield and qualification assumptions support each project’s contribution, and what capital remains?
  5. Will December receivables-purchaser commitments renew at similar pricing, advance rates and collateral terms?
  6. Why did pledged unsold receivables increase, and how would those assets behave during a customer-default stress?
  7. Which ordinary-debt, liquidity and return thresholds govern discretionary repurchases?
  8. What are final disposal proceeds after tax and closing adjustments, retained indemnities and earnings surrendered?
  9. What Canadian investment and operating commitments remain, and are they embedded in disclosed capex?
  10. Can both return measures improve without increasing exclusions from the capital denominator?

No complete current consensus distribution, consistently rebuilt historical valuation percentile or exhaustive insider census was established. Those gaps limit precision and positioning claims. They do not justify carrying prior conclusions forward as facts.

Economic maintenance also remains unresolved. Sustaining capex is a management classification; recurring productivity, compliance and logistics expenditures can preserve rather than expand earnings. Forecasts that remove every dollar labeled growth risk overstating post-construction cash. The most useful disclosure would combine net synergies, project investment, normal operating capital and realized cash in one consistent bridge. [S3]

What Must Be True

Bull tests

The earnings floor must survive normalization. Normal-crop adjusted EPS should remain at least $10 through 2027 without another discrete policy windfall. Monitor formal guidance, regional spreads, comparable segment contribution and ADM. Guidance below $8.50 or an adjusted segment-EBIT decline greater than 25% during ordinary capacity normalization would materially challenge the premise. These thresholds are analyst rules, not company commitments. [S2][S4][S19]

The identified operating bridge must become visible. Projects, incremental savings and commercial opportunities should deliver a substantial part of the approximately $1.50 management estimate. Monitor qualified sales, utilization, integration cash costs and a reconciled net-benefit bridge. Delivery below half without a specific temporary explanation falsifies the assumed execution pace. Missing attribution disclosure is an information gap; demonstrated economic underdelivery is stronger evidence. [S4][S8]

Returns must improve on consistently measured capital. Inventory-adjusted ROIC should move above 10%, with the less inventory-adjusted 7.0% measure also rising. Monitor profit, acquisition assets, construction transfers, inventory and financing together. Improvement created mainly by excluding more capital while cash returns stagnate fails the economic test. [S3]

Funding must remain available and stabilize. December purchaser commitments should renew, liquidity should remain adequate after CP backing and ordinary debt should stop rising once crop prices and activity stabilize. Monitor collateral, margin deposits and unused committed capacity. Adjusted leverage above 2.5 times alongside cash use and no credible remedy breaches the financing premise; changes in inventory credit must be distinguished from actual borrowing growth. [S1][S3][S23]

The network and allocation must protect per-share economics. During regional weakness, useful utilization and contribution should hold up without disproportionate additional capital. Compare matched peer periods after portfolio and timing adjustments. A large new debt-funded acquisition or aggressive distribution before financing stabilizes would contradict the assumed discipline. Actual net share retirement, project cash returns and ordinary debt are the relevant scorecard. [S1][S4][S19][S48]

Bear tests

The uplift must prove predominantly cyclical. New supply or weaker joint-product balances must compress contribution enough to offset execution. Monitor meal realization, crush utilization, peer profit and both return measures. Sustained $10-plus EPS with improving less inventory-adjusted returns through softer benchmark spreads would falsify this premise. [S3][S17][S19]

Capital absorption must persist beyond a credible normal explanation. The skeptical funding case weakens if operating capital converts without material losses, CFO becomes positive after total capex and ordinary debt declines while projects contribute. Repeated delays without a price-and-volume bridge strengthen the concern. Adjusted FFO alone cannot resolve it. [S1][S3][S4]

Commercial gains must disappoint or remain economically indistinguishable from spreads. A bridge connecting procurement, routing and utilization to recurring net contribution and required capital would weaken the skeptical attribution. Benefits retained after regional disruption normalizes are more persuasive than claims made during that disruption. Failure to disclose is weaker evidence than demonstrably poor net returns. [S4][S8]

Policy and projects must fail to deliver adequate returns. Monitor final exemption treatment, eligible feedstocks, physical oil use, customer acceptance and after-tax cash contribution. Strong consumption alone does not falsify the bear case; strong consumption with retained margins and adequate capital returns would. Projects reaching qualified utilization without repeated extra investment would likewise weaken the execution skepticism. [S13][S15][S16][S49]

Verdict: Resilient earnings, consistently measured returns, stable financing and actual cash realization must reinforce one another. Operating progress is visible; durable shareholder cash remains the principal unproven condition.

Core sources for verification: September 2026 Form 10-Q, Q3 results, Q3 call, Investor Day, EPA proposal, EIA physical inputs, and Canadian merger conditions.

Public source appendix

  • S1: Bunge September 2026 Form 10-Q — Primary SEC quarterly filing; published 2026-10-29; Cover; statements pp. 3–8; Notes 2, 4, 5, 11, 13, 15, 17–19; MD&A liquidity and controls.
  • S2: Bunge third-quarter 2026 earnings release — Primary company results; published 2026-10-29; pp. 1–9 results, segments and outlook; pp. 12–22 reconciliations.
  • S3: Bunge third-quarter 2026 earnings presentation — Primary company presentation; published 2026-10-29; Slides 7–12 allocation and returns; slides 25–31 EBITDA, leverage, cash and ROIC reconciliations.
  • S4: Bunge third-quarter 2026 earnings-call transcript — Primary management commentary; published 2026-10-29; pp. 6–16 Q&A: working capital, Q4, projects, annual savings, commercial gains and 2027; cross-checked with Company Financials.
  • S5: Bunge 2025 Form 10-K — Primary audited annual filing; published 2026-02-19; Items 1, 1A, 7 and 8; audited statements and acquisition, debt, equity and segment notes.
  • S6: Bunge 2024 Form 10-K — Primary audited annual filing; published 2025-02-20; Audited statements; Item 7 debt and commercial-paper backing; Note 22 shares; registered security and redomestication.
  • S7: Bunge 2023 Form 10-K — Primary audited annual filing; published 2024-02-22; Audited 2021–23 statements; Item 7 cash bridge and Note 4 securitization structure change.
  • S8: Bunge 2026 Investor Day presentation — Primary company strategy presentation; published 2026-03-10; Slides 30, 74, 77–81 and 105–108; $190M annual savings versus $220M exit run rate; EPS, interest, returns and allocation.
  • S9: Bunge June 2026 Form 10-Q — Primary SEC quarterly filing; published 2026-07-29; Statements; acquisition, inventory, receivables, debt and equity notes; repurchase table.
  • S10: Bunge second-quarter 2026 earnings-call transcript — Primary management commentary; published 2026-07-29; Prepared remarks and Q&A on guidance, projects, synergies and working-capital allocation; Company Financials cross-check.
  • S11: Bunge 2026 definitive proxy — Primary proxy filing; published 2026-04-10; pp. 18, 40–41, 46–68 and pay-versus-performance table; governance, metrics, 59% payout and compensation.
  • S12: Bunge executive integration incentive Form 8-K — Primary compensation filing; published 2026-04-01; Item 5.02: one-time award and cumulative run-rate synergy performance in 2026–28.
  • S13: EPA final renewable-fuel standards for 2026 and 2027 — Primary government regulation; published 2026-03-27; Applicable-volume table and RIN unit definition; final rule publication April 1.
  • S15: Proposed additional 2025 exemption reallocation — Primary proposed rule; published 2026-10-16; 91 FR 65699–65711: additional 770M RINs, timing alternatives, hearing and comment deadline.
  • S16: EIA soybean-oil inputs to biofuel production — Primary government statistics; published 2026-10-30; Million-pound monthly series through August 2026; 2025/26 rows; YTD totals independently calculated.
  • S17: USDA Oil Crops Outlook, October 2026 — Primary agricultural forecast; published 2026-10-14; OCS-26j pp. 1–4; 2026/27 production, crush and stocks; finalized 2025/26 crush.
  • S18: USDA soybean-oil biofuel-use outlook — Primary government analysis; published 2026-10-29; 17.8B-pound marketing-year forecast and recent crush-capacity context.
  • S19: ADM second-quarter 2026 results — Primary peer results; published 2026-08-04; Outlook; AS&O $867M versus $379M and timing commentary; adjusted-ROIC reconciliation.
  • S20: Company Financials — BG daily prices with public corroboration — Retrieved market data and public cross-check; published 2026-10-30; Public end-of-day page independently confirms October 30 OHLC and $96.64 close. Five-year split-adjusted history was separately retrieved from Company Financials for NYSE:BG: 1,256 observations, October 29, 2021–October 30, 2026, two complete pages. The public link is corroboration, not a permalink to that retrieved dataset.
  • S22: The factor model, October 30, 2026 — Supplied internal statistical diagnostic; published 2026-10-30; Supplied exposures, residual signals and diagnostics; R-squared 0.228625 and adjusted R-squared 0.209786.
  • S23: Bunge revolving-credit extensions Form 8-K — Primary financing filing; published 2026-09-21; Item 8.01; $1.1B, $4.2B and $3.5B facilities extended effective October 2–3.
  • S24: Bunge chief legal officer succession Form 8-K — Primary management filing; published 2026-10-05; Item 5.02; Walker appointment November 9 and Podwika transition.
  • S25: Bunge accounting leadership succession Form 8-K — Primary management filing; published 2026-09-03; Item 5.02; Simmons retirement, James succession and no-disagreement statement.
  • S27: Julio Garros September 2026 Form 4 — Primary insider filing; publication date unavailable; September 1 transaction: code A, 253 units; dividend-feature footnote.
  • S28: Greg Heckman September 2026 Form 4 — Primary insider filing; publication date unavailable; September 1 transaction: code A, 992 units; dividend-feature footnote.
  • S29: Company Financials — ADM prices with public corroboration — Retrieved market data and public cross-check; published 2026-10-30; Public dated quote confirms $76.91 close. Company Financials supplied NYSE:ADM daily split-adjusted observations September 10–October 30, 2026: 37 dates and 36 matched returns with BG; regression independently recalculated. Public URL corroborates the close, not the complete retrieved dataset.
  • S31: Bunge 2022 Form 10-K — Primary audited annual filing; published 2023-02-24; Audited statements, original EPS and securitization classification disclosures.
  • S32: Bunge 2021 Form 10-K — Primary audited annual filing; published 2022-02-18; Cash-flow statement F-7/PDF p. 73: CFO, capex and beneficial-interest proceeds and payments.
  • S44: Bunge September 2025 Form 10-Q — Primary quarterly filing; published 2025-11-05; Cash-flow statement: nine-month capex used with FY2025 and 9M2026 for trailing calculation; acquisition consolidation.
  • S45: Bunge March 2026 Form 10-Q — Primary quarterly filing; published 2026-04-29; Statements and MD&A: Q1 outlook context, post-merger perimeter and finance.
  • S46: European Council deforestation-free products timetable — Primary regulatory explanation; publication date unavailable; Application dates: December 30, 2026 for larger operators; traceability requirements.
  • S47: Canadian Competition Bureau Bunge–Viterra review — Primary competition analysis; published 2024-04-22; Executive summary and oilseed-market analysis: seven of fourteen facilities and defined local competition concerns.
  • S48: Canada Gazette Bunge–Viterra approval order — Primary government approval; published 2025-01-25; P.C. 2025-2; binding schedule: divestitures, G3 safeguards, investment and operations, section 21 price protection.
  • S49: Treasury and IRS proposed clean-fuel credit regulations — Primary tax guidance announcement; published 2026-02-03; IR-2026-20: extension through 2029, feedstock origin and proposed implementation.
  • S50: IRS Notice 2026-53, Internal Revenue Bulletin 2026-41 — Primary tax guidance; published 2026-10-05; Notice 2026-53: section 45Z emissions-rate and modeling guidance.